• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Early Ghrelin Suppression Following Glucose Intake Differs Across Weight Categories

by
November 15, 2026
in Health
Reading Time: 6 mins read
0
Early Ghrelin Suppression Following Glucose Intake Differs Across Weight Categories

Early Ghrelin Suppression Following Glucose Intake Differs Across Weight Categories

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Early suppression of circulating total ghrelin concentrations following an oral glucose challenge varies significantly according to body mass index, while the presence of reactive hypoglycemia does not alter this initial hormonal decline, according to a cross-sectional clinical study published in Frontiers in Endocrinology. Conducted by an endocrine research team at the Medical University of Bialystok in Poland, the investigation assessed 150 adult participants stratified across normal-weight, overweight, and obese categories to elucidate how nutritional state and postprandial glycemic drops interact with hunger hormone dynamics. While postprandial ghrelin suppression has been documented in metabolic research, the behavior of this peptide during subsequent phases of declining blood glucose, particularly within individuals experiencing symptomatic reactive hypoglycemia across diverse body compositions, has remained incompletely characterized in clinical endocrinology.

Metabolic flexibility describes the physiological capacity of an organism to adapt endocrine and metabolic signaling rapidly in response to continuous fluctuations in nutrient availability. Obesity and escalating insulin resistance systematically impair this adaptive responsiveness long before clinical disruptions in fasting blood glucose become detectable through routine laboratory screening. Although reactive hypoglycemia has historically been considered an outcome tied directly to severe insulin resistance, hyperinsulinemia, and excess adiposity, growing clinical evidence indicates that symptomatic postprandial glycemic crashes also occur frequently among normal-weight individuals exhibiting normal fasting glucose and preserved insulin sensitivity. This phenomenon indicates that mechanisms extending beyond classic pancreatic beta-cell dysregulation and insulin hypersecretion, specifically altered gastrointestinal and gastric peptide secretion patterns, may participate in postprandial hypoglycemic pathophysiology. Because overweight and obesity currently affect over one billion individuals globally, determining how adiposity shapes counter-regulatory and appetite-regulating hormonal trajectories during glucose loading provides fundamental insights into postprandial physiology and broader cardiometabolic disease risk profiles.

To examine dynamic ghrelin responses under standardized physiological provocation, the investigators screened 200 potential volunteers and enrolled 150 adults at the Department of Endocrinology, Diabetology and Internal Medicine at the Medical University of Bialystok. To eliminate confounding variables known to alter endocrine regulation and glucose kinetics, the cohort was restricted to non-smoking adults reporting no alcohol abuse and taking no medications capable of modifying carbohydrate metabolism. Individuals diagnosed with preexisting chronic illnesses, active endocrine disorders, or systemic inflammatory conditions were rigorously excluded. The enrolled participants were categorized into three distinct body mass index brackets of exactly 50 individuals each: normal-weight individuals with a body mass index below 25 kilograms per square meter, overweight individuals spanning 25 to 29.9 kilograms per square meter, and individuals with obesity exhibiting a body mass index equal to or exceeding 30 kilograms per square meter. Within each body mass index tier, participants were evaluated and divided according to the clinical occurrence of reactive hypoglycemia during prolonged testing.

Every participant underwent an overnight fast followed by a standardized 75-gram, 240-minute oral glucose tolerance test designed specifically for experimental evaluation. Reactive hypoglycemia was diagnosed when an individual displayed adrenergic or neuroglycopenic symptoms alongside a verified venous plasma glucose concentration dropping below 70 milligrams per deciliter at predefined sampling intervals of 120, 180, or 240 minutes. Among the 50 normal-weight subjects, 23 met the diagnostic criteria for reactive hypoglycemia while 27 served as non-hypoglycemic controls; among the 50 overweight participants, 26 developed reactive hypoglycemia and 24 served as controls; and within the 50 participants with obesity, 28 experienced reactive hypoglycemia while 22 served as controls. One additional overweight subject experienced a hypoglycemic event at 60 minutes and was excluded from subsequent analyses because the crash took place prior to the predefined late monitoring phase. Anthropometric assessments included height, weight, waist circumference, and hip circumference, complemented by multifrequency bioelectrical impedance analysis using an InBody 220 analyzer to quantify skeletal muscle mass, adipose tissue mass, and visceral fat distribution.

Venous blood samples were systematically collected to evaluate comprehensive biochemical and endocrine profiles, including fasting lipid fractions, glycated hemoglobin, liver enzymes, electrolytes, calcium, phosphate, 25-hydroxyvitamin D, thyroid-stimulating hormone, adrenocorticotropic hormone, and cortisol. Plasma glucose and insulin concentrations were determined at baseline, 60, 120, 180, and 240 minutes to establish glycemic context across the entire four-hour testing timeframe. Total serum ghrelin concentrations were quantified via validated enzyme-linked immunosorbent assay kits in duplicate within a single analytical batch to avoid inter-assay drift and observer bias. Ghrelin was measured at baseline fasting and at 60 minutes in all 150 participants to evaluate early postprandial suppression following oral carbohydrate ingestion. In participants who developed reactive hypoglycemia, an additional serum ghrelin measurement was collected at the exact documented time of symptomatic hypoglycemia. Importantly, control participants did not undergo late ghrelin sampling because they maintained plasma glucose levels above the hypoglycemic threshold throughout the full duration of testing.

Statistical evaluation revealed that serum total ghrelin concentrations decreased significantly from fasting baseline to 60 minutes across both reactive hypoglycemia and control cohorts in all three body mass index categories. Pairwise comparisons evaluating absolute ghrelin levels between participants with reactive hypoglycemia and matched control subjects at fasting and 60 minutes demonstrated no statistically significant differences after applying the Holm correction for multiple testing. Linear mixed-effects modeling incorporating all participants demonstrated an overall significant reduction in circulating ghrelin over time, alongside a negative main effect for the reactive hypoglycemia group characterized by a model coefficient beta of negative 522.11 picograms per milliliter. However, the interaction term between time and reactive hypoglycemia status was not statistically significant, yielding a beta of negative 2.02 picograms per milliliter. This absence of interaction confirms that the early rate of postprandial ghrelin suppression between fasting and one hour does not differ between individuals who subsequently develop reactive hypoglycemia and those who maintain stable glucose concentrations.

While reactive hypoglycemia status exerted no detectable influence on early ghrelin decline, body mass index emerged as a significant modifier of postprandial hormone suppression. In a combined linear mixed-effects model testing baseline and 60-minute measurements, the interaction between time and body mass index category was statistically significant, accompanied by a significant ordered trend across increasing adiposity classifications. Model-estimated changes confirmed pairwise differences between normal-weight and overweight cohorts, normal-weight and obese cohorts, and overweight and obese cohorts. Within the reactive hypoglycemia subgroup, median individual ghrelin suppression from baseline to 60 minutes was negative 1124 picograms per milliliter in normal-weight participants, negative 1088 picograms per milliliter in overweight participants, and negative 761 picograms per milliliter in participants with obesity. Across the entire cohort of 150 adults, the signed magnitude of early ghrelin change correlated inversely with continuous body mass index, waist-to-hip ratio, fasting insulin, HOMA-IR, and circulating triglycerides, illustrating that increasing adiposity blunts early postprandial suppression.

Among participants experiencing reactive hypoglycemia, circulating ghrelin concentrations rebounded upward, measuring higher at the documented hypoglycemic episode than at the 60-minute post-challenge nadir across all body composition categories. Unadjusted group comparisons indicated that the absolute late increase from 60 minutes to hypoglycemia differed across weight categories, with normal-weight individuals displaying the greatest rise at a median of 1842 picograms per milliliter, overweight individuals exhibiting 1560 picograms per milliliter, and obese individuals showing the smallest increase at 866 picograms per milliliter. Relative percentage increases similarly appeared blunted in obesity, measuring 58.4 percent, 55.2 percent, and 49.8 percent, respectively. However, the clinical timing of hypoglycemia varied considerably, occurring at 120 minutes in 2 normal-weight participants, at 180 minutes in 47 participants across categories, and at 240 minutes in 28 participants. When statistical models accounted for these unequal time intervals between measurements, the association between body mass index category and late ghrelin change lost statistical significance.

The attenuation of statistical significance after controlling for timing highlights critical physiological and methodological nuances in interpreting endocrine counter-regulation. Because the interval between the 60-minute draw and the hypoglycemic draw ranged from one to three hours, dynamic hormone concentrations could not be evaluated as a uniform late-phase response across all subjects. Furthermore, because control participants did not provide blood samples at parallel late time points, researchers could not determine whether the late increase in ghrelin represented a specific counter-regulatory defense triggered by hypoglycemia or simply reflected normal physiological recovery of hunger signaling following nutrient clearance. Another crucial interpretive constraint stems from the laboratory quantification of total circulating ghrelin rather than separate measurement of acylated and desacylated isoforms. Consequently, the observed findings reflect global peptide dynamics rather than isolated counter-regulatory pathway activation.

The investigators highlighted several inherent study limitations, noting that the cross-sectional observational design precludes establishing directional causality between altered ghrelin kinetics and insulin resistance or body composition. Conducted at a single medical center, the investigation featured relatively modest subgroup sample sizes that limited statistical power after rigorous multi-comparison corrections. Furthermore, although the sex distribution was comparable between cohorts, female hormonal phases, including menstrual cycle timing and menopausal status, were not experimentally controlled, leaving potential gonadal hormone interactions unaccounted for. Body composition was assessed through bioelectrical impedance rather than high-resolution imaging modalities such as dual-energy X-ray absorptiometry or magnetic resonance imaging. Future research directions proposed by the authors include longitudinal interventional trials examining whether lifestyle-induced weight reduction restores ghrelin dynamics, continuous glucose monitoring paired with simultaneous acylated and desacylated ghrelin profiling, and synchronized tracking of classic counter-regulatory mediators including glucagon, cortisol, adrenocorticotropic hormone, and catecholamines across uniform postprandial intervals in both hypoglycemic and normoglycemic individuals.

Subject of Research: Dynamic ghrelin regulation during oral glucose tolerance testing and reactive hypoglycemia across body mass index categories

Article Title: Ghrelin responses to oral glucose and reactive hypoglycemia across BMI categories

Article References: Buczyńska-Backiel, A., Kościuszko, M., Sobieska, K., Żuk, K., Krętowski, A. J., & Popławska-Kita, A. (2026). Ghrelin responses to oral glucose and reactive hypoglycemia across BMI categories. Frontiers in Endocrinology, 17, Article 1943944. https://doi.org/10.3389/fendo.2026.1943944

Image Credits: AI Generated

DOI: 10.3389/fendo.2026.1943944

Keywords: ghrelin, reactive hypoglycemia, oral glucose tolerance test, body mass index, insulin resistance, postprandial glucose, HOMA-IR, bioelectrical impedance analysis, endocrinology, energy homeostasis, obesity, fasting insulin, waist to hip ratio, metabolic flexibility, glucose counter regulation, visceral adipose tissue, total ghrelin

News Source: Ophelia Keating. (November 15, 2026). Early Ghrelin Suppression Following Glucose Intake Differs Across Weight Categories. Scienmag.

Tags: bioelectrical impedance analysisbody-mass indexEndocrinologyenergy homeostasisfasting insulinghrelinglucose counter regulationHOMA-IRinsulin resistancemetabolic flexibilityobesityOral glucose tolerance testpostprandial glucosereactive hypoglycemiatotal ghrelinvisceral adipose tissueWaist-to-Hip Ratio
Share12Tweet7Share2ShareShareShare1

Related Posts

UT-Hopkins Score Accurately Distinguishes Viral and Autoimmune Encephalitis in Chinese Cohort

UT-Hopkins Score Accurately Distinguishes Viral and Autoimmune Encephalitis in Chinese Cohort

November 20, 2026
Rabbit Study Compares Lingual and Bladder Mucosa Grafts for Ureteral Repair

Rabbit Study Compares Lingual and Bladder Mucosa Grafts for Ureteral Repair

November 20, 2026

PCDHGC3 Promoter Methylation Distinguishes Adrenocortical Carcinoma From Benign Tumors

November 20, 2026

Forebrain Organoid Multi-Omics Reveals Stage-Specific Molecular Defects in Rett Syndrome

November 20, 2026

POPULAR NEWS

  • Astrocytic GFAP Upregulation Reduces Tau Pathology in Mouse Model of Tauopathy

    Astrocytic GFAP Upregulation Reduces Tau Pathology in Mouse Model of Tauopathy

    29 shares
    Share 12 Tweet 7
  • Acidic Ponds Link to Lower Pathogen Prevalence in Palmate Newts

    29 shares
    Share 12 Tweet 7
  • Early YAP and Beta-Catenin Signaling Links Stomach Infection to Liver Colonization

    29 shares
    Share 12 Tweet 7
  • Cold Storage Preserves Peach Firmness by Triggering RNA Degradation of Expansin Transcripts

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

UT-Hopkins Score Accurately Distinguishes Viral and Autoimmune Encephalitis in Chinese Cohort

Rabbit Study Compares Lingual and Bladder Mucosa Grafts for Ureteral Repair

PCDHGC3 Promoter Methylation Distinguishes Adrenocortical Carcinoma From Benign Tumors

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.